Terms: = Colorectal cancer AND uPA AND Prognosis
27 results:
1. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
[TBL] [Abstract] [Full Text] [Related]
2. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
[TBL] [Abstract] [Full Text] [Related]
3. Stromal coexpression of upa/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Singer CF; Filipits M; Jahn SW; Abete L; Jakesz R; Greil R; Bauernhofer T; Kwasny W; Seifert M; Fitzal F; Kastner M; Schmitt M; Moinfar F; Gnant M
Breast; 2019 Aug; 46():101-107. PubMed ID: 31132475
[TBL] [Abstract] [Full Text] [Related]
4. Urokinase-type plasminogen activator receptor (upaR) expression enhances invasion and metastasis in RAS mutated tumors.
Mauro CD; Pesapane A; Formisano L; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Monteleone F; Zambrano N; Fontanini G; Servadio A; Pignataro G; Grumetto L; Lavecchia A; Bruzzese D; Iaccarino A; Troncone G; Veneziani BM; Montuori N; Placido S; Bianco R
Sci Rep; 2017 Aug; 7(1):9388. PubMed ID: 28839232
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical prospects of tumor-associated proteases and their tissue inhibitors investigation in oncologic patient].
Gershteĭn ES; Kushlinskiĭ NE
Vestn Ross Akad Med Nauk; 2013; (5):16-27. PubMed ID: 24000664
[TBL] [Abstract] [Full Text] [Related]
6. Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.
Lin Y; Peng N; Li J; Zhuang H; Hua ZC
Mol Cancer; 2013 Jun; 12():54. PubMed ID: 23758884
[TBL] [Abstract] [Full Text] [Related]
7. Gelsolin induces colorectal tumor cell invasion via modulation of the urokinase-type plasminogen activator cascade.
Zhuo J; Tan EH; Yan B; Tochhawng L; Jayapal M; Koh S; Tay HK; Maciver SK; Hooi SC; Salto-Tellez M; Kumar AP; Goh YC; Lim YC; Yap CT
PLoS One; 2012; 7(8):e43594. PubMed ID: 22927998
[TBL] [Abstract] [Full Text] [Related]
8. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
[TBL] [Abstract] [Full Text] [Related]
9. The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition.
Jacobsen B; Ploug M
Curr Med Chem; 2008; 15(25):2559-73. PubMed ID: 18855679
[TBL] [Abstract] [Full Text] [Related]
10. Differential proteome expression associated with urokinase plasminogen activator receptor (upaR) suppression in malignant epithelial cancer.
Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
[TBL] [Abstract] [Full Text] [Related]
11. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
[TBL] [Abstract] [Full Text] [Related]
12. Polymorphisms in the genes of the urokinase plasminogen activation system in relation to colorectal cancer.
Försti A; Lei H; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Ann Oncol; 2007 Dec; 18(12):1990-4. PubMed ID: 17804466
[TBL] [Abstract] [Full Text] [Related]
13. Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer.
Seetoo DQ; Crowe PJ; Russell PJ; Yang JL
J Surg Oncol; 2003 Mar; 82(3):184-93. PubMed ID: 12619063
[TBL] [Abstract] [Full Text] [Related]
14. Cyclooxygenase-2 expression correlates with upaR levels and is responsible for poor prognosis of colorectal cancer.
Konno H; Baba M; Shoji T; Ohta M; Suzuki S; Nakamura S
Clin Exp Metastasis; 2002; 19(6):527-34. PubMed ID: 12405290
[TBL] [Abstract] [Full Text] [Related]
15. Significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) expression in human colorectal carcinomas.
Papadopoulou S; Scorilas A; Yotis J; Arnogianaki N; Plataniotis G; Agnanti N; Talieri M
Tumour Biol; 2002; 23(3):170-8. PubMed ID: 12218297
[TBL] [Abstract] [Full Text] [Related]
16. Plasmin/plasminogen system in colorectal cancer.
Berger DH
World J Surg; 2002 Jul; 26(7):767-71. PubMed ID: 11965442
[TBL] [Abstract] [Full Text] [Related]
17. High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.
Nordengren J; Fredstorp Lidebring M; Bendahl PO; Brünner N; Fernö M; Högberg T; Stephens RW; Willén R; Casslén B
Int J Cancer; 2002 Jan; 97(3):379-85. PubMed ID: 11774293
[TBL] [Abstract] [Full Text] [Related]
18. Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer.
Konno H; Abe J; Kaneko T; Baba M; Shoji A; Sunayama K; Kamiya K; Tanaka T; Suzuki S; Nakamura S; Urano T
Jpn J Cancer Res; 2001 May; 92(5):516-23. PubMed ID: 11376560
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic importance of the soluble plasminogen activator receptor, supaR, in plasma from rectal cancer patients.
Fernebro E; Madsen RR; Fernö M; Brünner N; Bendahl P; Christensen IJ; Johnson A; Nilbert M
Eur J Cancer; 2001 Mar; 37(4):486-91. PubMed ID: 11267858
[TBL] [Abstract] [Full Text] [Related]
20. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size.
Abe J; Urano T; Konno H; Erhan Y; Tanaka T; Nishino N; Takada A; Nakamura S
Cancer; 1999 Dec; 86(12):2602-11. PubMed ID: 10594855
[TBL] [Abstract] [Full Text] [Related]
[Next]
